The European Association for Cardio-Thoracic Surgery has withdrawn its support for the left main disease recommendations of the 2018 European Association for Cardio-Thoracic Surgery/European Society of Cardiology Clinical Guidelines for Myocardial Revascularization, but a portion of the association’s explanation has drawn criticism from the Society for Cardiovascular Angiography and Interventions.
A team of surgeons and specialists at Massachusetts General Hospital (MGH) is announcing an achievement in transplant surgery today, having recently performed the largest number of adult heart transplants in the country using what are known as Donation after Circulatory Death (DCD) donor hearts.
A UVA Health proposal to reduce hospital readmissions was among 25 submissions chosen – from more than 300 applications – for a national competition seeking ideas on how artificial intelligence can improve healthcare.
In patients with stable CAD who are experiencing symptoms, very low levels of cardiac troponin I measured with a high-sensitivity assay do not reliably exclude the presence of inducible myocardial ischemia on stress testing, new Swiss data show.
Reflow Medical announces that the Temporary Spur Stent System, a novel retrievable stent technology intended for the treatment of below-the-knee (BTK) peripheral artery disease, has been designated for the Breakthrough Devices Program by the U.S. Food and Drug Administration (FDA).
Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) approval of a new alternative surgical technique for Abbott’s HeartMate 3 heart pump that will allow more advanced heart failure patients to avoid open heart surgery.
The American Society of Echocardiography (ASE) has updated its guidelines for using echocardiography to image ischemia.
Training for six months and completing your first marathon can add back up to four years in your heart health, according to a new study.
Research from the Society of Nuclear Medicine and Molecular Imaging indicates that a new form of positron emission tomography (PET) scanning can effectively image fibroblast activation after a heart attack.
Catheter ablation is currently the most effective treatment for atrial fibrillation (AF).1,2 It is widely performed in various centers around the world given the increasing prevalence of AF in the population and the modest response to antiarrhythmic medications.
With the advancements in therapeutic options offered in today’s cardiac electrophysiology (EP) practice, as well as the increased complexity of patients with congenital and acquired heart disease requiring invasive procedures to treat heart rhythm disorders, there is an increased need for cardiac electrophysiologists to better understand the complexity of their patients’ unique cardiac anatomy.
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!